The Jassim and Hamad Bin Jassim Charitable Foundation has signed a co-operation agreement with the Qatar Cancer Society (QCS), under which the Foundation provides the QCS QR500 000 as a contribution to support the treatment of cancer patients who cannot afford the costs of treatment.
The agreement was signed by Member of the Board of Directors and CEO of Jassim and Hamad bin Jassim Charitable Foundation, Saeed Mathkar al-Hajri, and the Qatar Cancer Society's Board Chairman HE Sheikh Dr Khalid bin Jabor al-Thani.
Saeed al-Hajri stressed that the Foundation always seeks to serve the local community with its own capabilities and resources.
The support provided to the Qatar Cancer Society, which amounts to QR500,000 comes within the framework of the existing co-operation between the Foundation and the Society to finance the treatment of cancer patients in Qatar and provide them with the necessary health services.
Al-Hajri added that the agreement aims to provide a mechanism and framework for co-operation with the Qatar Cancer Society, which deals with community awareness to prevent cancer and works to support people with this disease.
The support provided is the first in light of the existing co-operation between the two parties, as the Foundation was keen to enhance its efforts in applying the principles of social responsibility, he added.
Al-Hajri noted that the agreement between the two parties provided an opportunity to build close partnerships within the framework of joint work to provide health and humanitarian services for cancer patients, and look forward to more joint cooperation in the future in order to activate the Foundation's vision of "health and education for a better life", and to translate these efforts within the framework of social responsibility and achieving goals humanity and patriotism.
For his part, HE Sheikh Dr Khalid bin Jabor al-Thani, Chairman of the Board of Directors of Qatar Cancer Society praised the efforts of the Jassim and Hamad bin Jassim Foundation in charitable and humanitarian work, especially in the health sector, and supporting the awareness-raising efforts carried out by the Society , especially in the field of supporting the treatment of cancer patients. The therapeutic cost of the disease remained high, which affected the health and psychological well-being of those living with it, he added.
He affirmed that Qatar Cancer Society has sought not to have one patient on the waiting list of support since its establishment in 1997, as it bore the treatment of 1,200 patients at a cost of approximately QR16.5mn during 2019.
The first quarter of this year witnessed treating 900 patients, at a total cost of approximately QR4.9mn.
He noted that the agreement is part of the role played by the two parties in community service and effective partnership that contributes to achieving the goals that are in the interest of society members and raising awareness and all that would serve their target groups, especially since the issue of cancer control needs to unite efforts and continue them in order to face the disease.
He added that the two sides are linked by permanent co-operation before the agreement, and each of them will strive to consolidate and strengthen this relationship by benefiting from their experiences and unifying efforts in the interest and benefit of all members of society.